.png?itok=e0cZg30u)
A study led by scientists at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) provides new insights into ventricular fibrillation (VF), the most dangerous type of cardiac arrhythmia.
The study, published in the journal Cardiovascular Research, demonstrates that electrical signals recorded during cardiac arrest caused by VF provide crucial information about damage to the heart and other vital organs, including the brain.
Ventricular fibrillation is one of the main causes of sudden cardiac death. An estimated 17,000 sudden cardiac deaths occur in Spain each year, most of them the result of malignant arrhythmias like VF. Most VF episodes occur outside hospital, where survival rates are significantly lower, at below 10%. Survival is so low because disorganized ventricular electrical activity immediately halts effective blood pumping, causing global ischemia and, if not reversed, death within minutes.
The study, led by Dr. David Filgueiras Rama, leader of the Advanced Development in Arrhythmia Mechanisms and Therapy group at the CNIC, also shows that the right ventricle is better able than the left ventricle to withstand the loss of blood perfusion and oxygen supply during cardiac arrest. “This difference generates electrical activation gradients in the heart that track the development of the underlying injury. Moreover, the surface electrocardiogram (ECG) signal during ventricular arrhythmia-associated cardiac arrest can be used to predict the likelihood of neurological recovery after hospital admission,” explains Dr. Filgueiras Rama.
The study found that these differences were more pronounced between the epicardium (outer heart surface) and the endocardium (inner surface), although differences were also maintained between the epicardial layers of the right and left ventricles. The greater resistance of the right ventricle was reflected in longer preservation of its native electrical activity, consistent with better metabolic preservation and greater tolerance of ischemia. These findings were confirmed by computer simulations performed in collaboration with the Universidad Politécnica de Valencia.
“The clinical results support the prognostic value of the surface ECG in cardiac arrest caused by ventricular fibrillation, showing that it can identify those patients who are more likely to recover without severe neurological sequelae,” says Dr. Filgueiras Rama.
Dr. Jorge García Quintanilla, a senior researcher in the CNIC group and a member of CIBERCV, the Spanish cardiovascular research network, adds that “the findings provide valuable information that could guide the development of therapies aimed at protecting the left ventricle and improving its resistance to ischemia during cardiac arrest.”
CNIC researcher Dr. Andrés Redondo Rodríguez, first author on the study and also a CIBERCV member, highlights the importance of a multidisciplinary approach to tackling complex arrhythmias such as VF, helping to drive the development of new therapies in a field that has seen limited progress in recent decades.
The study was conducted through collaboration with the following institutions: Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC); Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV); Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Centro de Investigación e Innovación en Bioingeniería (Ci2B) de la Universidad Politécnica de Valencia, Fundación Interhospitalaria para la Investigación Cardiovascular (FIC) and Universidad Complutense de Madrid..
The study was funded by the Cardiac Rhythm Association of the Spanish Society of Cardiology (2020 research grants); the Spanish Ministry of Science and Innovation (MCIN) (PID2023-150456OB-I00) through MCIN / AEI / 10.13039/501100011033; the Community of Madrid (S2022/BMD-7229, Arcadia); and the Carlos III Health Institute (ISCIII) / MCIN / European Union NextGenerationEU / PRTR (PMP22/00185). The study was also partially funded by the Interhospital Foundation for Cardiovascular Research (FIC, Madrid, Spain)..
Jonatan R. Ruiz is a full professor in the Faculty of Sports Sciences at the University of Granada, Spain. He holds a PhD in Exercise Physiology from the University of Granada and a PhD in Medical Sciences from the Karolinska Institutet in Sweden. He was also the first Ramón y Cajal research fellow in Spain to come from the field of Sports Sciences.
Jonatan Ruiz co-leads the PROFITH CTS-977 research group and serves as Scientific Director of a CIBEROBN group focused on exercise and obesity. He is also Director of the University Sport and Health Joint Institute (iMUDS) at the University of Granada.
Throughout his research career, Dr. Ruiz has focused on the impact of physical exercise on energy metabolism and cardiovascular health, particularly in relation to obesity and insulin resistance. In recent years he has led several clinical studies in Spain on time-restricted eating—one of the most widely studied forms of intermittent fasting—and its interaction with exercise.
Intermittent fasting involves alternating periods of eating with periods of fasting—something we actually do naturally every day: we eat during the day and then sleep through the night without taking in any food. In a basic sense, that already counts as a form of intermittent fasting.
When we talk about intermittent fasting as a nutritional strategy, however, we are referring mainly to extending or structuring those fasting periods more deliberately. One straightforward approach, for example, involves a full 24-hour fast during which only water, coffee, or non-caloric drinks are permitted, after which the person returns to eating relatively freely the following day.
The form of intermittent fasting we have been studying is known as time-restricted eating. What does that mean in practice? In Spain, the average eating window tends to run for between 12 and 13 hours—we have breakfast at seven or eight in the morning and dinner at eight or nine in the evening. That is the span between the first and last meal of the day.
Time-restricted eating means compressing that window from 12 hours down to around 8, leaving approximately 16 hours of fasting. During that time you can drink water freely, as well as unsweetened coffee or tea, but no food or caloric beverages.
Yes. The scientific evidence shows that simply limiting food intake to a shorter time window can lead to weight loss and improvements in cardiovascular health.
Among the most notable are better blood glucose regulation and a reduction in subcutaneous abdominal fat. People who follow this nutritional pattern also tend to lose more body weight overall, accompanied by decreases in visceral and liver fat. My recommendation would be to follow a 16:8 pattern and to aim to finish eating two or three hours before going to bed. If you go to sleep at eleven, ideally you would not be eating dinner after eight. And that last meal should be light—high in protein and fiber, and not too substantial.
I completely agree, and it’s something I experience at home myself. I practice intermittent fasting: I skip breakfast and don’t eat until midday or even three in the afternoon. That runs slightly against my own preferences, because I love breakfast.

The other difficulty is that dinner in Spain has a social dimension. In my household, if I skip dinner one evening it almost becomes a family event: “What do you mean you’re not eating?” That social pressure is real, and it was one of the challenges we wanted to assess in the study.
The research was conducted in Granada and Pamplona—two quite different cities—and we were struck by how high the adherence levels were. On average, participants stuck to the protocol six days out of seven. The day they tended to relax the rules was usually at the weekend, which is entirely understandable.
Participants said they felt better, and many said they wanted to maintain this way of eating. When we followed up a year later, we found that while not everyone had kept it up continuously, many had returned to it during particular periods.
There was also one factor we hadn’t anticipated: many people told us that the fasting helped them organize their lives and establish a sense of routine. “I know I’m going to eat between twelve and eight; I check the clock and that’s it.” No calorie counting, no measuring portions constantly.
Yes, though not consciously. Participants ended up consuming between 300 and 500 fewer calories per day, and that reduction largely explains the weight loss.
When someone knows they are on a diet and needs to restrict calories, a persistent sense of hunger often sets in. With this approach, by contrast, the strategy is simply about controlling when you eat.
I think the 16:8 pattern is probably the most straightforward and sustainable option. My recommendation would be to concentrate eating within an eight-hour window and to avoid eating during the two to three hours before sleep, with a light evening meal that is rich in protein and fiber.
Exactly. The study ran for three months, and to assess how much of the effect persisted, we contacted participants again a year later.
The surprising finding was that a year on, participants had retained a large part of the body weight reduction they had achieved over the three months of intermittent fasting.
In ongoing studies in women with obstructive sleep apnea, we have also incorporated psychological treatment into the lifestyle intervention. This makes a significant difference when it comes to consolidating behavioral change.
What we do is an intensive eight-week program in which participants come to the center once a week. A psychologist begins the work using cognitive behavioral therapy to equip participants with tools for modifying habits that have been ingrained over decades. This is followed by nutritional education, guidance on sleep hygiene, alcohol and tobacco, and physical exercise.
The changes we see in just eight weeks are remarkable, and more than 70% of participants no longer need CPAP (continuous positive airway pressure therapy). In fact, the women tell us they don’t want us to let them go. But we remind them that they now have everything they need, and that maintaining these habits is down to them. And indeed, when we call them six months later, many are continuing to improve.
Several key factors are at play here. One is cognitive behavioral therapy, which helps people understand why change matters. Another is that the lifestyle modifications we propose are small and realistic. We are not telling someone to go to the gym five days a week—that is simply not viable for most people. It is small, sustained changes that can generate major long-term benefits.
We believe that the fundamental factor is sleep. When someone is sleeping badly, their quality of life deteriorates enormously. But once they start sleeping better, they quickly begin to identify which habits are helping them.
Start with a 16:8 pattern, aim to finish your last meal two to three hours before going to bed, and keep that evening meal light—high in protein and fiber, and not too large.

On the occasion of his participation as a jury member in the 2026 Rei Jaume I Awards, Aaron Ciechanover, awarded the 2004 Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation, visited today the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and Miguel Hernández University (UMH) of Elche. Professor Ciechanover was accompanied by Elena Bendala, from the Rei Jaume I Awards Foundation, and they were received by the UMH Vice-Rector for Research, Ángel Carbonell; the deputy directors of the IN, Guillermina López Bendito and Santiago Canals; the founder of the Institute for Neurosciences, Carlos Belmonte; and the UMH Deputy Vice-Rector for Research Management and Knowledge Transfer, Javier Sáez Valero.

Visit of Professor Aaron Ciechanover to the CSIC-UMH Institute of Neurosciences on the occasion of his participation as a jury member in the 2026 Rei Jaume I Awards. Source: IN CSIC-UMH
The visit began with an institutional welcome and a general presentation of the IN CSIC-UMH, after which the Nobel Prize laureate toured some of the center’s most representative scientific facilities. In particular, he visited the Magnetic Resonance and Molecular Imaging Service and the Omics and Gene Analysis Service, where he was able to learn first-hand about their capabilities and lines of research, accompanied by their scientific directors and technical staff. He also visited the Altered Molecular Mechanisms in Alzheimer’s Disease and Dementia laboratory, led by researcher Javier Sáez Valero.
The programme concluded with a meeting with the centre’s research staff, where the scientist exchanged views on current challenges in biomedical research and reflected on his scientific career. Such meetings contribute to strengthening dialogue between leading international figures in science and the institute’s research community.
In this regard, the Director of the Institute for Neurosciences, Juana Gallar, highlighted the importance of Aaron Ciechanover’s visit for the centre: “His scientific career is an example of the value of basic research in transforming our understanding of biology and opening new avenues to understand and treat diseases”. “Having internationally leading scientists among us allows us to share perspectives on some of the major challenges in biomedical research and highlights the scientific excellence developed at our institute”, she added.
2004 Nobel Prize in Chemistry
Aaron Ciechanover (Haifa, Israel, 1947) is a biologist and Distinguished Professor at the Technion–Israel Institute of Technology. In 2004, he was awarded the Nobel Prize in Chemistry together with Avram Hershko and Irwin Rose for the discovery of the ubiquitin–proteasome system, responsible for the selective degradation of proteins in cells. This discovery transformed the understanding of cellular mechanisms that regulate essential processes such as cell division, DNA repair, immune response, and programmed cell death, and has had a profound impact on the study of diseases such as cancer, neurodegenerative disorders, and various genetic pathologies.
Throughout his scientific career, Professor Ciechanover has made fundamental contributions to the field of cell biology and biomedicine, with a particular interest in protein degradation mechanisms and their implications in human disease. His work has been widely recognized with numerous international awards and academic distinctions, and has helped establish the ubiquitin–proteasome system as one of the central pathways in the regulation of cellular physiology.
Source: Institute for Neurosciences CSIC-UMH (in.comunicacion@umh.es)
La entrada The Institute for Neurosciences CSIC-UMH receives the visit of Aaron Ciechanover, 2004 Nobel Prize in Chemistry se publicó primero en Instituto de Neurociencias de Alicante.
A ferret, a mouse, a chicken, and a snake walk into a bar… This is how researcher Eduardo Fernández Ortuño begins his social media post. In an Instagram carousel, he explains how the brain develops during the embryonic stage and the differences that distinguish birds, reptiles, and mammals. His science communication adaptation of his doctoral research in the #HiloTesis format has been selected as a local finalist at Miguel Hernández University of Elche (UMH) in the sixth edition of the competition, organized by the Conference of Rectors of Spanish Universities (CRUE).
In his doctoral thesis, supervised by Víctor Borrell, researcher at the Institute for Neurosciences, a joint center of UMH and the Spanish National Research Council (CSIC); Eduardo Fernández investigates why the cerebral cortex of birds, reptiles, and different mammals initially develops in a very similar way during the early embryonic stages, but later follows different developmental paths in species with folded brains, such as humans. “A large part of the answer lies in the way the cortex generates neurons during development”, explains the researcher.
During embryonic development, different types of neural progenitor cells divide and produce new neurons, which in mammals migrate along radial glial fibers until they reach their final position in the cerebral cortex. However, this growth process does not occur in the same way across all species. While in mammals progenitor cells generate the large number of neurons that will form the neocortex, the development of this brain region is more limited in birds and reptiles.

Images from the Instagram carousel through which Eduardo Fernández Ortuño participates in #ThesisThread. Source: UMH.
This growth is not uniform: while some regions expand considerably and form folds or gyri, others grow less and give rise to the characteristic grooves of the human brain. Furthermore, in mammalian species with larger brains, neocortical growth becomes so extensive that it eventually folds into the distinctive gyri and sulci observed in species such as ferrets and humans.
This brain folding is essential for proper brain organization, as alterations in the process can lead to severe neurological and cognitive disorders. Some rare diseases are associated with mutations that prevent the normal formation of these folds. For this reason, basic research is crucial for understanding these conditions and advancing toward future therapies. Comparisons with birds and reptiles may provide key insights into the specific properties of neural progenitor cells in mammals.
Eduardo Fernández Ortuño’s research is supported by the “la Caixa” Foundation, as well as by the Severo Ochoa Programme for Centres of Excellence in R&D and the Spanish Ministry of Science, Innovation and Universities.
#HiloTesis is an initiative promoted by CRUE and the Network for Science Outreach and Culture (RedDivulga). In the 2026 edition, more than 250 participants from Spanish universities took part. A jury will select the six best science communication entries among all finalists chosen by each university. The winning entries will receive a prize of €500 thanks to the support of the Ignacio Larramendi Foundation.
Source: UMH Communication Office (comunicacion@umh.es)
The original press release can be found in the attached file.
La entrada Eduardo Fernández Ortuño, local finalist in the #HiloTesis competition se publicó primero en Instituto de Neurociencias de Alicante.
Abstract: The ab initio approach to nuclear structure allows us to describe atomic nuclei with controlled and systematically improvable approximations. Applying it to nuclei that are at the same time both heavy and open-shell is largely impossible with current many-body techniques. This is due to the computational cost of handling huge dense tensors.
I will show how some surprisingly simple tricks may help us to tackle this hurdle. These tricks are driven by the observation that different contributions to ab initio calculations describe different physics. We leverage this by using adapted model spaces.
In addition, we use modern linear algebra methods to develop dimensionality reduction techniques based on the singular value decomposition. By avoiding the construction of large many-body tensors in the first place, we are able to extend the reach of ab initio calculations to nuclei where standard approaches would be too expensive to run.